- Home
- RGLS vs IAF Comparison
RGLS vs IAF Comparison
Compare RGLS & IAF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGLS
- IAF
- Stock Information
- Founded
- RGLS 2007
- IAF 1985
- Country
- RGLS United States
- IAF United States
- Employees
- RGLS N/A
- IAF N/A
- Industry
- RGLS Biotechnology: Pharmaceutical Preparations
- IAF Finance/Investors Services
- Sector
- RGLS Health Care
- IAF Finance
- Exchange
- RGLS Nasdaq
- IAF Nasdaq
- Market Cap
- RGLS 102.1M
- IAF 122.2M
- IPO Year
- RGLS 2012
- IAF N/A
- Fundamental
- Price
- RGLS $1.42
- IAF $4.50
- Analyst Decision
- RGLS Strong Buy
- IAF
- Analyst Count
- RGLS 6
- IAF 0
- Target Price
- RGLS $10.33
- IAF N/A
- AVG Volume (30 Days)
- RGLS 493.3K
- IAF 90.4K
- Earning Date
- RGLS 11-07-2024
- IAF 01-01-0001
- Dividend Yield
- RGLS N/A
- IAF 11.44%
- EPS Growth
- RGLS N/A
- IAF N/A
- EPS
- RGLS N/A
- IAF N/A
- Revenue
- RGLS N/A
- IAF N/A
- Revenue This Year
- RGLS N/A
- IAF N/A
- Revenue Next Year
- RGLS N/A
- IAF N/A
- P/E Ratio
- RGLS N/A
- IAF N/A
- Revenue Growth
- RGLS N/A
- IAF N/A
- 52 Week Low
- RGLS $1.08
- IAF $3.60
- 52 Week High
- RGLS $3.79
- IAF $4.59
- Technical
- Relative Strength Index (RSI)
- RGLS 41.95
- IAF 45.66
- Support Level
- RGLS $1.36
- IAF $4.48
- Resistance Level
- RGLS $1.65
- IAF $4.58
- Average True Range (ATR)
- RGLS 0.10
- IAF 0.06
- MACD
- RGLS -0.01
- IAF 0.00
- Stochastic Oscillator
- RGLS 28.57
- IAF 38.83
About RGLS Regulus Therapeutics Inc.
Regulus Therapeutics Inc is a biotechnology company focused on the development of microRNA therapies. MicroRNA therapies target diseases such as cancer, metabolic diseases, fibrosis, and inflammatory diseases. The product candidate of the company is RGLS8429, an anti-miR next-generation oligonucleotide targeting miR-17 for the treatment of autosomal dominant polycystic kidney disease (ADPKD), and is in Phase 1b clinical development.
About IAF abrdn Australia Equity Fund Inc.
Aberdeen Australia Equity Fund Inc is a non-diversified closed-end investment management company. With a core focus on long-term capital appreciation, it invests predominantly in equity securities listed on the Australian Stock Exchange. Its secondary objective is current income, which it expects to derive from dividends and interest on Australian corporate and governmental securities. Its investment portfolio comprises diversified sectors that include Financials, Health Care, Materials, Information Technology, Real Estate, and other sectors.